Malignancy Risk of Mycophenolate Mofetil and Azathioprine in Fibrotic ILD
Are patients with fibrotic interstitial lung disease at risk of malignancy when treated with the immunomodulatory drugs MMF and AZA?
Pulmonary Fibrosis
Can BMI and Weight Loss Predict Mortality in Fibrotic Interstitial Lung Disease?
Researchers assessed whether BMI and weight loss are reliable prognostic indicators in patients with fibrotic interstitial lung disease.
Pulmonary Rehab for Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
A review of 21 studies evaluated the long-term outcomes associated with pulmonary rehabilitation for patients with pulmonary fibrosis, including ILD.
Predictors of Disease Progression and Mortality in Non-IPF Fibrosing ILD
The researchers sought to identify predictors of disease progression and mortality in non-IPF fILD using criteria from the INBUILD, RELIEF, and uILD trials.
Switching Antifibrotic Agents May Improve Outcomes in Idiopathic Pulmonary Fibrosis
Because the 2 antifibrotics in use — pirfenidone and nintedanib — have differing mechanisms of action, when one is ineffective the other may provide benefit, thus improving survival.
Time to Death, Lung Transplant Not Reduced With Co-Trimoxazole in Moderate, Severe IPF
Trimethoprim-sulfamethoxazole therapy did not reduce time to death, lung transplant, or hospitalization in patients with moderate or severe idiopathic pulmonary fibrosis.
Review Provides Insights Into Pulmonary Hypertension Among Patients With Pulmonary Fibrosis
The understanding of the role of specific molecular mechanisms causing pulmonary hypertension in people with pulmonary fibrosis is growing but still in its infancy.
Combination Metformin and Low-Dose Nintedanib Reduces Pulmonary Fibrosis
Metformin was effective in reducing pulmonary fibrosis in human IPF fibroblasts and when used in combination with low-dose nintedanib, demonstrated a synergistic, antifibrotic effect.
Double Lung Transplantation Improves Survival in Interstitial Pulmonary Fibrosis
Double lung transplantation appears to offer superior survival outcomes to single lung transplantation in patients with interstitial pulmonary fibrosis who are younger than 70 years.
Idiopathic Pulmonary Fibrosis in Dentists May Be Linked to Occupational Exposure
Several patients were treated for idiopathic pulmonary fibrosis were identified as dental personnel.
- Loading...
Loading...
Next post in Restrictive Lung Disease
Loading... 
Loading...